RDVT Beats on All Fronts as Stock Rallies 6%
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Red Violet just delivered the clearest signal it has given investors all year — a Q1 earnings beat that landed after the close on May 6, with the stock already up 6% on the week heading into the print.
The numbers were unambiguous. Adjusted EPS came in at $0.46 against a $0.32 estimate — a 44% beat. Revenue of $25.83M topped the $24.63M consensus by $1.2M. The company's full-year 2025 result had already demonstrated the growth trajectory: revenue rose from $75.2M to $90.3M and net income nearly doubled from $7M to $13.2M. Q1 2026 carries that momentum forward. RDVT's EPS surprise factor score ranks in the 79th percentile — consistent with a company that has made a habit of clearing the bar. Analysts' consensus mean target at $63.50 implies roughly 57% upside from the current $40.42 close, though those targets — last formally updated in April 2026 from B. Riley's October 2025 raise to $62 — may already be under revision after tonight's beat.
The Street's existing coverage is thin but uniformly bullish. B. Riley reiterated Buy with a $62 target in October 2025. Lake Street initiated at Buy in August 2025. No analyst carries a Sell rating. The valuation picture is reasonable for the growth on offer: EV/EBITDA on forward estimates is approximately 14x, and EV/EBIT near 27x — not cheap, but consistent with a profitable, cash-generating SaaS-adjacent data company in growth mode. The EV figure available in the data reflects 2025 figures and may be stale relative to today's market cap; treat the multiples as indicative rather than precise.
Positioning heading into the print was defensive but not aggressive. Short interest at 5.2% of the float is real but not extreme, and the position barely moved over the past week — shares short ticked up just 0.06%. Cost to borrow dropped sharply, from nearly 3.4% on April 28 down to 0.62% by May 5, suggesting shorts are not expanding and borrow pressure has eased. Availability is wide; the lending market here is loose, not stressed. The ORTEX short score of 46 is mid-range, well below any warning-zone reading. Options positioning was the one area of caution: the put/call ratio held near 1.52, above its 20-day average of 1.16, pointing to investors hedging ahead of results. With the beat now confirmed, those hedges may unwind.
The ownership base reflects a stock that attracts engaged institutional holders. Wasatch Advisors added 110,421 shares in Q1 2026, lifting their stake to 6.46% — one of the more meaningful additions in recent quarters. Vanguard and BlackRock each hold around 6.4-6.8%. CEO Derek Dubner holds roughly 3.7% of the company. The insider picture shows coordinated December 2025 sales by Dubner, CFO MacLachlan, President Reilly, and CIO Dell — all at prices around $55.87 — likely pre-planned disposals given the simultaneous nature. The stock now trades well below those December exit prices, which adds some context to the rally: insiders sold near highs and the stock retraced before this week's move.
What to watch next: RDVT is scheduled to present at the Needham Technology Conference (May 12-14) and the B. Riley Institutional Investor Conference (May 20-21) — both opportunities for management to address the Q1 beat and any forward-year guidance revision. Whether analyst targets get formally lifted to reflect tonight's beat and the pace of revenue acceleration will set the near-term re-rating narrative.
Stocks in this article
See the live data behind this article on ORTEX.
Open RDVT on ORTEX →How this article was generated
- Generated
- 6 May 2026, 21:51
- Data as of
- 6 May 2026, 21:44
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signals
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.